Bayer is facing billions of dollars in exposure from a growing number of lawsuits over PCB products. Read more at ...

Faced with huge debt, the impending expiry of a crucial patent, and ongoing litigation over a horror acquisition, Bayer CEO Bill Anderson made a bold move a year ago to get his damaged company ...

Bayer expects its pharmaceutical business to return to growth in 2027 as the launch new therapies is expected to offset ...

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

Bayer said Thursday it has acquired camelina germplasm, intellectual property, and materials from Smart Earth Camelina Corp.

Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...

Registered Dietitian and Nutritionist Kelly Bristow from Bayer shares five simple tips to help families start the year strong ...

“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...

Bayer (OTCPK:BAYRY) said that phase 3 data on its experimental MRI contrast agent gadoquatrane met primary and secondary ...

Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company has announced the acquisition of Tavros Therapeutics, ...